Glucose News and Research

RSS

Patent pending discovery could help type 2 diabetics

Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."

4 Oct 2004

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

The National Institutes of Health (NIH) announced today that it plans to award about $75 million over five years to five clinical centers and a data coordinating center to conduct studies of islet transplantation in patients with type 1 diabetes.

4 Oct 2004

Research confirms benefits of commonly used traditional remedies for a range of illnesses

Research presented to the British Pharmaceutical Conference today, confirms the benefits of commonly used traditional remedies for a range of illnesses, including cancer, offering a scientific justification for their use.

29 Sep 2004

People with diabetes may soon be able to swap their tablets for creams and ointments

This news will come as a relief for type 2 diabetes patients who are routinely treated with oral hypoglycaemic drugs to lower their blood glucose levels. These can cause severe gastrointestinal side effects, such as nausea, vomiting and diarrhoea.

27 Sep 2004

New methods for the growth and development of human pancreatic beta islets

Vitro Diagnostics has announced the development of new methods for the growth and development of human pancreatic beta islets (Islets of Langerhans) and the filing of a new patent application with the United States Patent and Trademark Office.

27 Sep 2004

Low paid civil servants were more likely to develop type 2 diabetes

London civil servants at the lower end of the employment scale and with lower social position were more likely to develop type 2 diabetes than those at higher employment levels, according to an article in the September 27 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Sep 2004

New book suggests foods with a low glycemic index are key to weight loss

Choosing foods with a low glycemic index is the key to successful and sustainable weight loss, according to a new book written by nutritionists from the University of Sydney.

23 Sep 2004

Evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes

Endocrinologists from the University at Buffalo are providing one more link in the growing chain of evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes.

21 Sep 2004

Stress response proteins offer a promising target for a novel drug guidance system

Their study, published in the September issue of the journal Cancer Cell, demonstrates how researchers can find protein tags that are unique to cancer cells and then tweak a drug delivery system to zero in on those tags and destroy the cells.

21 Sep 2004

Link between elevated blood sugar levels in diabetics and increased risk of life-threatening forms of cardiovascular disease

A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.

20 Sep 2004

Research findings may help stave off full-blown diabetes

A new study by researchers at Joslin Diabetes Center sheds light on the key mechanisms by which new pancreatic beta cells normally form in response to insulin resistance. These findings may some day help researchers devise ways of staving off full-blown diabetes.

18 Sep 2004

New culprit behind the brain injury suffered by stroke victims

Researchers have uncovered a new culprit behind the brain injury suffered by stroke victims. Their new study, published in the Sept. 17 issue of Cell, links brain cell damage to a rise in brain acidity following the oxygen depletion, or ischemia, characteristic of stroke.

18 Sep 2004

Slimming agents could pose major health risk

Commonly used nutritional supplements and body-building agents for elite athletes could pose an increased risk of cancer according to a study undertaken at the University of Sydney.

16 Sep 2004

Red Bull energy drink does not improve a person’s physical performance

Energy drinks – usually a mixture of caffeine, taurine, carbohydrates, B-complex vitamins and gluconolactone – have become very popular in recent years.

15 Sep 2004

Micro-thin implantable films may one day allow patients to forgo daily injections and pills

Researchers at the Georgia Institute of Technology have developed a material that may one day allow patients to forgo daily injections and pills and receive prescriptions instead through micro-thin implantable films that release medication according to changes in temperature.

14 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Exubera shows sustained blood glucose control in patients with type 2 diabetes

New data showed that Exubera (inhaled insulin) was effective and well tolerated in controlling blood glucose levels over a two-year period in patients with Type 2 diabetes.

8 Sep 2004

Summary of The Euro Heart Survey on the diabetic state of patients with coronary artery disease

The survey engaged 110 centres in 25 countries recruiting 4,196 patients referred to a cardiology department or outpatient clinic due to CAD. A total of 2 107 of these patients were admitted on acute basis while 2,854 had an elective consultation. Patient data were collected via a web-based case record form.

30 Aug 2004

New study confirms benefits of rimonabant in weight loss

Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight

29 Aug 2004

Tomato juice may help type 2 diabetics

Tomato juice may be the key to decreasing hyperactive platelet aggregation, which can lead to heart disease, according to the latest nutrition and dietetics study by HMRI researchers based at the University of Newcastle.

27 Aug 2004